Medications

Trump unveils plan to reduce US pharmaceutical prices

President Donald Trump outlined plans Friday to reduce soaring US prescription drug prices, among the highest in the world, but opposition Democrats accused him of falling short of his election campaign promises.

Cardiology

Outcomes-based pricing doesn't cut costs of PCSK9 inhibitors

(HealthDay)—Outcomes-based pricing does not reduce the costs of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, according to a research letter published online April 3 in the Annals of Internal Medicine.

Medications

Drug makers engage in 'co-opetition' through drug middlemen

Prescription drug consumers confounded by the cost of their medications can get a peek behind the curtain thanks to new Washington University in St. Louis research into the complex "co-opetition"—cooperation and competition—among ...

Oncology & Cancer

Markups for oncology services vary at the hospital level

(HealthDay)—There is significant variation in markup of outpatient oncology services across hospitals in the United States, according to a study published online Feb. 17 in the American Journal of Managed Care.

page 35 from 40